Download PDF
Zentralbl Chir 2006; 131(3): 235-239
DOI: 10.1055/s-2006-933468
Der interessante Fall

© Georg Thieme Verlag Stuttgart · New York

Schilddrüsenmetastasen eines Nierenzellkarzinoms - drei Fallvorstellungen und Übersicht der Literatur

Renal Cell Carcinoma Metastases to the Thyroid Gland - Report of 3 Cases and Review of the LiteratureI. Iesalnieks1 , M. Woenckhaus2 , G. Glockzin1 , H. J. Schlitt1 , A. Agha1
  • 1Klinik und Poliklinik für Chirurgie, Universitätsklinikum Regensburg
  • 2Institut für Pathologie, Universitätsklinikum Regensburg
Further Information

Publication History

Publication Date:
31 May 2006 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Klinisch relevante, isolierte Metastasen eines malignen Tumors in der Schilddrüse stellen eine absolute Rarität dar. Der Primarius findet sich meist in der Niere in Form eines hellzelligen Nierenzellkarzinoms. Eine Besonderheit dieser klinischen Situation ist ein relativ spätes metachrones Auftreten: eine isolierte Schilddrüsenmetastasierung tritt durchschnittlich 100-120 Monate nach Entfernung des Primärtumors auf. Die operative Sanierung sollte angestrebt werden, da nach Resektion solitärer Schilddrüsenmetastasen eines Nierenzellkarzinoms eine 5-Jahres-Überlebensrate von bis zu 50 % erreicht werden kann. Wir berichten über drei Patienten mit operativ entfernten Schilddrüsenmetastasen eines Nierenzellkarzinoms und liefern eine Literaturübersicht zu diesem Thema.

Abstract

Clinically significant, solitary metastasis to the thyroid gland is a rare occurrence. The clear cell carcinoma of the kidney (RCC) is the most common primary tumor site. Late recurrence is a notable feature of renal carcinoma. Solitary metastases in the thyroid gland occur as late as 100-120 months from the date of nephrectomy. There is a clear survival benefit in selected cases if surgical approach to the thyroid metastases is chosen. In those patients who have undergone complete resection, 5-year-survival-rates of 50 % have been reported. We describe 3 cases of surgically treated thyroid metastases of RCC, and review the literature.

Schlüsselwörter

Nierenzellkarzinom - Metastasen - Schilddrüse

Key words

renal cell carcinoma - metastases - thyroid gland

Literatur

  • 1 Chen H, Nicol T L, Udelsman R. Clinically significant, isolated metastatic disease to the thyroid gland.  World J Surg. 1999;  23 177-180
    CrossrefPubMedGoogle Scholar
  • 2 Congiu A, Nicolosi A, Malloci A, Piga A, Calo P G, Murtas M G. Metastasi tiroidea e cutanea isolate de carcinoma renale.  Minerva Chir. 1994;  49 223-227
    PubMedGoogle Scholar
  • 3 Curti B D. Renal cell carcinoma.  JAMA. 2004;  292 97-100
    CrossrefPubMedGoogle Scholar
  • 4 DiBiase S J, Valicenti R K, Schultz D, Xie Y, Gomella L G, Corn B W. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model.  J Urol. 1997;  158 746-749
    CrossrefPubMedGoogle Scholar
  • 5 Ericsson M, Biorklund A, Cederquist E, Ingemansson S, Akerman M. Surgical treatment of metastatic disease in the thyroid gland.  J Surg Oncol. 1981;  17 15-23
    PubMedGoogle Scholar
  • 6 Gault E W, Leung T H, Thomas D P. Clear cell renal carcinoma masquerading as thyroid enlargement.  J Pathol. 1974;  113 21-25
    PubMedGoogle Scholar
  • 7 Heffess C S, Wenig B M, Thompson L D. Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases.  Cancer. 2002;  95 1869-1878
    CrossrefPubMedGoogle Scholar
  • 8 Hudson M A, Kavoussi L R, Catalona W J. Bilateral renal cell carcinoma with metastasis to thyroid.  Urology. 1991;  37 145-148
    CrossrefPubMedGoogle Scholar
  • 9 Jadvar H, Kherbache H M, Pinski J K, Conti P S. Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma.  Clin Nephrol. 2003;  60 395-400
    PubMedGoogle Scholar
  • 10 Kang D E, White Jr  R L, Zuger J H, Sasser H C, Teigland C M. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.  J Urol. 2004;  171 1806-1809
    CrossrefPubMedGoogle Scholar
  • 11 Kavolius J P, Mastorakos D P, Pavlovich C, Russo P, Burt M E, Brady M S. Resection of metastatic renal cell carcinoma.  J Clin Oncol. 1998;  16 2261-2266
    CrossrefPubMedGoogle Scholar
  • 12 Kierney P C, van Heerden J A, Segura J W, Weaver A L. Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review.  Ann Surg Oncol. 1994;  1 345-352
    CrossrefPubMedGoogle Scholar
  • 13 Leibovich B C, Blute M L, Cheville J C, Lohse C M, Frank I, Kwon E D, Weaver A L, Parker A S, Zincke H. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.  Cancer. 2003;  97 1663-1671
    Google Scholar
  • 14 Majhail N S, Urbain J L, Albani J M, Kanvinde M H, Rice T W, Novick A C, Mekhail T M, Olencki T E, Elson P, Bukowski R M. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.  J Clin Oncol. 2003;  21 3995-4000
    CrossrefPubMedGoogle Scholar
  • 15 Masuda H, Kawakami S, Nagamatsu H, Nagahama K, Yamada T, Negishi T. [Two cases of thyroid metastases from renal cell carcinoma].  Hinyokika Kiyo. 1992;  38 821-824
    PubMedGoogle Scholar
  • 16 McCabe D P, Farrar W B, Petkov T M, Finkelmeier W, O'Dwyer P, James A. Clinical and pathologic correlations in disease metastatic to the thyroid gland.  Am J Surg. 1985;  150 519-523
    CrossrefPubMedGoogle Scholar
  • 17 Michelow P M, Leiman G. Metastases to the thyroid gland: diagnosis by aspiration cytology.  Diagn-Cytopathol. 1995;  13 209-213
    PubMedGoogle Scholar
  • 18 Motzer R J, Bacik J, Murphy B A, Russo P, Mazumdar M. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.  J Clin Oncol. 2002;  20 289-296
    CrossrefPubMedGoogle Scholar
  • 19 Nakahara H, Noguchi S, Murakami N, Tamura S, Jinnouchi S, Kodama T, Adjei O N, Nagamachi S, Ohnishi T, Futami S, Flores 2nd  L G, Watanabe K. Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.  Radiology. 1997;  202 765-772
    PubMedGoogle Scholar
  • 20 Nakhjavani M K, Gharib H, Goellner J R, van Heerden J A. Metastasis to the thyroid gland. A report of 43 cases.  Cancer. 1997;  79 574-578
    CrossrefPubMedGoogle Scholar
  • 21 Pagano S, Franzoso F, Ruggeri P. Renal cell carcinoma metastases. Review of unusual clinical metastases, metastatic modes and patterns and comparison between clinical and autopsy metastatic series.  Scand J Urol Nephrol. 1996;  30 165-172
    PubMedGoogle Scholar
  • 22 Palazzo F F, Bradpiece H A, Morgan M W. Renal cell carcinoma metastasizing to the thyroid gland.  Scand J Urol Nephrol. 1999;  33 202-204
    PubMedGoogle Scholar
  • 23 Piltz S, Meimarakis G, Wichmann M W, Hatz R, Schildberg F W, Fürst H. Long-term results after pulmonary resection of renal cell carcioma metastases.  Ann Thorac Surg. 2002;  73 1082-1087
    CrossrefPubMedGoogle Scholar
  • 24 Ritchie A W, Chisholm G D. The natural history of renal carcinoma.  Semin Oncol. 1983;  10 390-400
    PubMedGoogle Scholar
  • 25 Shimaoka K, Sokal J E, Pickren J W. Metastatic neoplasms in the thyroid gland. Pathological and clinical findings.  Cancer. 1962;  15 557-565
    CrossrefPubMedGoogle Scholar
  • 26 Silverberg S G, Sokal J E, Pickren J W. Metastatic tumors in the thyroid.  Pacif Med Surg. 1966;  74 175-180
    PubMedGoogle Scholar
  • 27 Stenzl A, deKernion J B. Pathology, biology, and clinical staging of renal cell carcinoma.  Semin Oncol. 1989;  16 3-11
    PubMedGoogle Scholar
  • 28 Takashima S, Takayama F, Wang J C, Saito A, Kawakami S, Kobayashi S, Sone S. Radiologic assessment of metastases to the thyroid gland.  J Comput Assist Tomogr. 2000;  24 539-545
    PubMedGoogle Scholar
  • 29 van der Poel H G, Roukema J A, Horenblas S, van Geel A N, Debruyne F M. Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis.  Eur Urol. 1999;  35 197-203
    CrossrefPubMedGoogle Scholar
  • 30 Wood K, Vini L, Harmer C. Metastases to the thyroid gland: the Royal Marsden experience.  Eur J Surg Oncol. 2004;  30 583-588
    CrossrefPubMedGoogle Scholar

Dr. I. Iesalnieks

Klinik und Poliklinik für Chirurgie · Universitätsklinikum Regensburg

Franz-Josef-Strauß-Allee 11

93053 Regensburg

Phone: 09 41/9 44 68 01

Fax: 09 41/9 44 68 02

Email: igors.iesalnieks@klinik.uni-regensburg.de

      >